Combination of negative pressure wound therapy and systemic steroid therapy in postsurgical pyoderma gangrenosum after reduction mammoplasty; a case of proven efficacy and safety by Tanini, Sara et al.
[page 50]                                                           [Dermatology Reports 2017; 9:7209]
Combination of negative pressure wound therapy and systemic steroid therapy in postsurgical pyoderma gangrenosum after reductionmammoplasty; a case of proven efficacy and safety
Sara Tanini, Gianmarco Calugi, 
Giulia Lo Russo
Plastic and Reconstructive
Microsurgery, Department of Surgery
and Translational Medicine, Careggi
University Hospital, Florence, Italy
Abstract
Pyoderma gangrenosum (PG) is a rare
non-infective inflammatory disease of
unknown etiology characterized by cuta-
neous papulo-pustoles that rapidly evolve
into painful ulcerative lesions.
Postoperative PG (PPG) is a clinical variant
of PG in which pathergic response occurs at
surgical sites. It is important to include PG
in the differential diagnosis of breast ulcer-
ation. An incorrect diagnosis and treatment
can potentially worsen the patient state,
causing disfigurement with extensive scar-
ring, an unpleasant aesthetic result and pro-
duce consequent psychological trauma. 
We report a case of PPG after bilateral
breast reduction mammoplasty treated with
negative pressure wound therapy (NPWT)
as local treatment for wound dehiscence in
combination with systemic steroid therapy.
This synergism led to a good aesthetic
result. NPWT improved wound perfusion, it
decreased the exudate, and promoted adher-
ence of the mammary gland to the pectoral
muscle. After 31 days deep sutures were
placed to directly close the wound and the
patient was discharged.
PPG is a rare, devastating occurrence
after surgery. Surgeons must know that PPG
is an evenience that can occur in otherwise
healthy patients and must be considered in
the differential diagnosis in case of necrotic
ulcers and apparent infection status. NPWT
resulted to have benefits in the treatment of
PPG, with a role in limiting the size of the
defect, avoiding pathergic self-reaction and
allowing a faster recovery with higher
chances of achieving a better result.
Introduction
Pyoderma gangrenosum (PG) is a rare
destructive, non-infective inflammatory
cutaneous disease of unknown etiology
characterised by cutaneous papulo-pustoles
that rapidly evolve into painful ulcerative
lesions.1 It belongs to the spectrum of neu-
trophilic dermatoses caused by genetic pre-
disposition and modified immune/inflam-
mation response.2,3 It is usually associated
with several diseases and has also been
reported as a complication of many surger-
ies.1,2 Postoperative PG (PPG) is a clinical
variant of PG in which pathergic response
occurs at surgical sites.2,4 It is important to
include PG in the differential diagnosis of
breast ulceration, because it is often initially
diagnosed as a wound infection but, antibi-
otic therapy and wound debridement fail to
arrest the rapid ulcer enlargement.5 PG
insidiously causes a rapid and devastating
soft tissue damage, the key points to avoid
an excessive surgical demolition and obtain
an acceptable outcome, are recognizing it
quickly and setting an appropriate therapy
in the least time possible; it can be especial-
ly important considering the aesthetic crite-
ria in breast surgery.1,3 We report a case of
PPG after breast reduction mammoplasty in
a young woman who had no history of asso-
ciated systemic disorder in which we
obtained a good aesthetic result with a com-
bination of negative wound therapy and
systemic steroid therapy.
Case Report
A 39-year-old woman was admitted to
our department requesting a bilateral breast
reduction after massive weight loss (Figure
1). Past medical history was unremarkable
and she underwent a previous gastric by-
pass as therapy to manage her severe obesi-
ty and a sequential abdominoplasty, without
any complications. An inverted T-shaped
reduction mammoplasty was performed in
standard fashion removing 490 g of tissue
from left breast and 520 g of tissue from
right breast. The immediate postoperative
course was uneventful. On postoperative
day 4, patient developed a fever of 38°C,
with severe pain (grade 7 of the visual ana-
log scale) and swelling of both breasts.
Breasts were unsymmetrically involved,
both presenting rapidly expanding necrotic
wound areas, surrounded by an erythema-
tous zone, with undermined borders.
Postoperative infectious cellulitis was sus-
pected and a blind antibiotic intravenous
treatment was given to the patient waiting
for the microbiological results and blood
cultures. On postoperative day 7 fever was
still present and the breast ulcer deteriorated
by 1 to 2 cm per day with an excruciating
pain (visual analog scale 9), and rapidly
developing a 10x5 cm of dimension cuta-
neous ulcer occupying the inferior half of
the left breast but relatively sparing part of
the areola and nipple. Along with the wors-
ening of local conditions we assisted at a
systemic drop with retro-nuchal pain, posi-
tive Lasegue’s sign and hemianopia of the
right eye. All these signs were orienting us
towards a septic state. The microbiological
cultures and the blood cultures for aerobic
and anaerobic bacteria came back negative,
so we proceeded to obtain tissue biopsies.
The patient underwent partial surgical
debridement and a local negative pressure
wound therapy (125 mmHg) was applied
bilaterally. Two days after there was a new
dehiscence in the surgical wound, with a
large area of necrosis without secretion.
Under analgesia the medications were
changed.
Seven days after the onset of symptoms
histological examination identified a non-
specific acute inflammatory process and
ulceration with necrosis and neutrophilic
infiltration into the dermis. A diagnosis of
PPG was made and a systemic corticos-
teroid therapy was started. Patient was treat-
ed at the time of diagnosis with IV metil-
prednisone (1.2 mg/kg/die) administration,
according to international guidelines for
PPG management, with a dramatic recov-
ery. In the following days, the patient’s con-
dition improved, and we were able to
observe granulation tissue, the contraction
of wound edges and an initial adherence
between tissues. NPWT was applied for one
month, and thirty-five days after the initial
procedure some stitches were applied to
increase improvements of the wound’s
appearance (Figure 2). The corticosteroids
dose was gradually reduced. 
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The synergy of systemic steroid therapy
and local negative pressure wound therapy
led to an acceptable result, despite PSPG is
a medical challenge. There has been a rapid
response and wound areas significantly
reduced. Wound bed showed an intensive
vascularization, granulation tissue and a
rapid contraction of wound edges, keeping
the left nipple-areola complex vital and
allowing a simple primary wound closure
(Figure 3).
Discussion
Pyoderma gangrenosum is a rare der-
matological disorder first described by
Brocq in 1916. PG is an uncommon neu-
trophilic dermatosis that presents as an
inflammatory and ulcerative disease of the
skin, characterized by atypical signs, simi-
lar to infection disease.3,6 PG is associated
with a variety of inflammatory diseases
(from 47.8% to 80%),1 most commonly
inflammatory bowel disease, rheumatoid
arthritis, hematologic disease and malig-
nancies.6 In up to 50% of cases, lesions
occur at sites of cutaneous trauma, a phe-
nomenon known as pathergy. These include
sites of venipuncture, laparoscopy, and sur-
gical incisions. Post-surgical pyoderma
gangrenosum refers to the development of
pyoderma gangrenosum at surgical sites in
the immediate post-operative period.5
Clinical aspects often mimic a suppurative
process. The initial signs of this condition
are represented by erythema, wound tender-
ness and wound dehiscence that may occur
from 4 to 14 days after the surgical proce-
dure. These lesions rapidly evolve with a
destructive, painful and progressive necrot-
ic process that usually involves deep tis-
sues.1,5-8
Although rare, PPG has been reported
following plastic surgery to the breast. PG
diagnosis after reductive mammoplasty is a
challenge because clinical signs resemble
an infectious process. Usually it is a diagno-
sis of exclusion based on clinical factors,
ulcerative characteristics, negativity of
microbiological culture and antibiotics
treatment failure.1,9 Some clinical character-
istics are usually associated with PPG: there
is often a bilateral involvement, with a pos-
sible pathognomonic feature represented by
the demarcated sparing of the nipple-areolar
complex despite extensive ulceration of the
surrounding skin. This striking observation
may help in the diagnostic workup by
excluding the other causes of necrosis such
as flap failure, infection and necrotizing
fasciitis in which the nipple-areolar com-
plex is usually involved.6
Inefficacy of systemic wide spectrum
antibiotic therapy, deterioration of patient’s
condition with a progressive wound
enlargement often lead surgeons to aggres-
sively debride the wound, worsening the
pathergy of the disease. The surgical man-
agement of active PPG ulcers is discour-
aged due to the risk of pathergy-associated
worsening.6,10 Early diagnosis and a correct
therapy are the keystones to reduce the need
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Figure 1. Frontal and lateral preoperative view.
Figure 3. Two months post op follow-up frontal and lateral view.
Figure 2. A) Six days after bilateral breast reduction mammoplasty. B) Nine days postop-
eratively. Increased area of necrosis and progressive aggravation of wound areas. The
patient underwent partial surgical debridement and a local negative pressure wound ther-
apy was applied bilaterally. C) Twenty days after initial procedure. Improved appearance
of the wound after 3 foam changes. D) Thirty-five days after initial procedure. To increase
the improvement of wound’s appearance some stitches were applied. 
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of secondary surgical procedures that lead
to a good aesthetic result.6
The goal of treatment is to limit tissue
destruction and promote wound healing.3,11
Even though there is no specific treatment
for PPG,12,13 immunomodulatory and
immunosuppressive systemic therapy are
the mainstay for the treatment of PG ulcers.
Corticosteroids in moderate to high doses
(prednisolone, 0.5-2 mg/kg/day) and
cyclosporine (3-6 mg/kg/day) are the most
frequently used drugs, and also the best
documented in literature.14 In 1997, Argenta
and Moryskwas, developed a commercial
product based on the use of negative pres-
sure and began to use it for wound treat-
ment, providing an excellent environment
for faster healing.11
The rational of the use of sub atmos-
pheric pressure therapy includes: i)
increased tissue perfusion;10 ii) control of
the advancing ischemic process; iii) rapid
production of a healthy granular wound
bed; iv) reduced bacterial load that provides
local control of the moisture, exudates and
edema besides achieving an important pain
relief.15
NPWT may have benefits in the treat-
ment of complicated breast incisions and
injuries. In literature there are descriptions
of the use of NPWT after breast surgery
such as autologus brest reconstrucion, addi-
tive mastoplasty, mastectomy, TRAM flap
necrosis and tissue expander infection. No
complications with the use of NPWT have
been reported.16
In our case we had a patient with a mas-
sive loss of mammary tissue bilaterally. On
one side we had the need to protect the sub-
stance loss from infection and reduce the
expansion of the ulcer, while on the other
side we needed to support the healing
process and obtain the best result possible.
These reasons lead us to a combined treat-
ment of negative wound pressure therapy
and systemic steroid therapy.
In our experience, the use of negative
pressure wound therapy improved wound
perfusion, decreased exudate, and promoted
adherence of the mammary gland to the
pectoral muscle. This led to an effective
local disease control, avoiding further need
of surgical escharectomy but most impor-
tantly, it permitted faster healing of the very
large ulcers of the patient, reducing signifi-
cantly wound dehiscence, with a complete
resolution of the erythematous undermined
borders. Despite patient’s pain, VAC thera-
py is well-tolerated.13
The time needed for complete healing
after PPG is described in the literature as
ranging from 1.5 months to 1 year (average,
5 months). After the third VAC foam
change, it was possible to place fastening
sutures between these tissues. Clinical fol-
low-up showed good results and a reduced
length of hospital stay according to litera-
ture.11
Use of NPWT for breast wounds might
be benefical as it is for other wounds.
However, large prospective controlled stud-
ies that compare standard treatment with the
use of NPWT are needed to evaluate the
main role of NPWT.16
Conclusions
PPG is a rare, devastating occurrence
after surgery. A conservative treatment was
the key to success. Surgeons must know
that PPG is an evenience that can occur in
otherwise healthy patients and must be con-
sidered in the differential diagnosis in case
of necrotic ulcers and apparent infection
status. In our case, the early recognition and
application of NPWT in combination with
systemic steroid therapy has limited the size
of the defect, avoiding pathergic self-reac-
tion and allowing a faster recovery with
higher chances of achieving a better result.
References
1. Abtahi-naeini B, Bagheri F, Pourazizi
M, et al. Unusual cause of breast
wound: postoperative pyoderma gan-
grenosum. Int Wound J 2017;14:285-7.
2. Larcher L, Schwaiger K, Eisendle K, et
al. Aesthetic breast augmentation
mastopexy followed by postsurgical
pyoderma gangrenosum (PSPG): clinic,
treatment, and review of the literature.
Aesth Plast Surg 2015;39:506-13.
3. Marinopoulos S, Theofanakis C,
Zacharouli T, et al. Pyoderma gan-
grenosum of the breast: a case report
study. Int J of Surg Case Rep 2017;
31:203-5.
4. Tolkachjov SN, Fahy AS, Wetter DA, et
al. Postoperative pyoderma gangreno-
sum (PG): the Mayo Clinic experience
of 20 years from 1994 through 2014. J
Am Acad Dermatol 2015;73:615-22.
5. Zuo KJ, Fung E, Tredget EE, Lin AN. A
systematic review of post-surgical pyo-
derma gangrenosum: identification of
risk factors and proposed management
strategy. J Plast Reconstr Aesthet Surg
2015;68:295-303.
6. Su WP, Davis MD, Weening RH, et al.
Pyoderma gangrenosum; clinicopatho-
logic correlation and proposed diagnos-
tic criteria Int J Dermatol 2004;43:790-
800.
7. Goshtasby PH, Chami RG, Michael R.
A novel approach to the management of
pyoderma gangrenosum complicating
reduction mammoplasty. Aesthet Surg J
2010;30:186-94.
8. Gameiro A, Pereira N, Cardoso JC,
Gonçalo M. Pyoderma gangrenosum:
challenges and solutions Clin Cosmet
Investig Dermatol 2015;28:285-93.
9. Duval A, Boissel N, Servant JM, et al.
Pyoderma gangrnosum of the breast: a
diagnosis not to be missed. J Plast
Reconstr Aesthet Surg 2011;64:17-20. 
10. Ghersi MM, Ricotti C, Nousari CH,
Newman MI. Negative pressure dres-
sing in the management of pyoderma
gangrenosum ulcer. Arch Dermatol
2007;143:1249-51.
11. Soncini JA, Grassi Salles A, Frizzo Neto
JA, Gemperli R. Successful treatment
of pyoderma gangrenous after augmen-
tation mastopexy using vacuum thera-
py. Plast Reconstr Surg Glob Open
2016;9:e1072.
12. Schintler MV, Grohmann M, Donia C,
et al. Management of
an unfortunate triad after breast recon-
struction: pyoderma gangrenosum, full-
thickness chest wall defect and
Acinetobacter baumannii infection. J
Plast Reconstr Aesthet Surg 2012;63:
564-7.
13. Callen JP. Pyoderma gangrenosum and
related disordes. Dermatol Clin
1990;7:1249.
14. Chow RKP, Ho VC. Treatment of pyo-
derma gangrenosum J Am Acad
Dermatol 1996;34:1047.
15. Fraccalvieri M, Fierro MT, Salomone
M, et al. Gauze-based negative pressure
wound therapy: a valid method to man-
age pyoderma gangrenosum. Int Wound
J 2014;11:164-8.
16. Namdaroğlu OB, Yazıcı H,
Müctebaztürk A, et al. Negative-pres-
sure wound therapy in chronic inflam-
matory breast diseases. J Breast Health
2016;12:91-3.
                             Case Report
No
n c
mm
erc
ial
 us
e o
nly
